Download PDF
Synlett 2015; 26(18): 2601-2605
DOI: 10.1055/s-0035-1560633
letter
© Georg Thieme Verlag Stuttgart · New York

Site-Selective Suzuki–Miyaura Reaction of 6,8-Dibromoflavone

Dávid Pajtás
a   Department of Organic Chemistry, University of Debrecen, Egyetem tér 1, 4032, Debrecen, Hungary
,
Károly Dihen
a   Department of Organic Chemistry, University of Debrecen, Egyetem tér 1, 4032, Debrecen, Hungary
,
Tamás Patonay
a   Department of Organic Chemistry, University of Debrecen, Egyetem tér 1, 4032, Debrecen, Hungary
,
Krisztina Kónya
a   Department of Organic Chemistry, University of Debrecen, Egyetem tér 1, 4032, Debrecen, Hungary
,
Alexander Villinger
b   Department of Chemistry, Organic Chemistry, University of Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany
,
Peter Langer*
b   Department of Chemistry, Organic Chemistry, University of Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany
c   Leibniz-Institute for Catalysis e.V. at the University of Rostock (LIKAT), Albert-Einstein-Str. 3a, 18059 Rostock, Germany
› Author Affiliations
Further Information

Publication History

Received: 14 July 2015

Accepted after revision: 18 September 2015

Publication Date:
18 September 2015 (online)

    Permissions and Reprints All articles of this category


Abstract

8-Aryl- and 6,8-diarylflavones were prepared by Suzuki–­Miyaura reactions of 6,8-dibromoflavone. In spite of the greater steric hindrance, the first attack proceeded with good site selectivity at position 8.

Key words

palladium - catalysis - flavones - Suzuki–Miyaura reaction - regioselectivity

Supporting Information

    Supporting information for this article is available online at http://dx.doi.org/10.1055/s-0035-1560633.
  • Supporting Information
 

  • References and Notes

    • 1a Harborne JB, Baxter H. The Handbook of Natural Flavonoids . Vol. 1. John Wiley and Sons; Chichester: 1999
      Google Scholar
    • 1b Römpp Lexikon Naturstoffe . Steglich W, Fugmann B, Lang-Fugmann S. Thieme; Stuttgart: 1997
      Article in Thieme ConnectGoogle Scholar
    • 1c Havsteen BH. Pharmacol. Ther. 2002; 96: 67
      CrossrefPubMed
    • 1d Beecher GR. J. Nutr. 2003; 133: 3248S
    • 1e Middleton Jr E, Kandaswami C, Theoharides TC. Pharmacol. Rev. 2000; 52: 672
    • 1f Harborne JB, Williams CA. Phytochemistry 2000; 55: 481
      CrossrefPubMed
    • 2a Rao YK, Fang SH, Tzeng YM. Bioorg. Med. Chem. 2005; 13: 6850
      CrossrefPubMed
    • 2b Wang SF, Jiang Q, Ye YH, Li Y, Tan RX. Bioorg. Med. Chem. 2005; 13: 4880
      CrossrefPubMed
    • 2c Daskiewies J, Depeint F, Viornery L, Bayet C, Geraldine C, Comte G, Gee J, Johnson I, Ndjoko K, Hostettmann K, Barron D. J. Med. Chem. 2005; 48: 2790
      CrossrefPubMed
    • 2d Gao H, Kawabata J. Bioorg. Med. Chem. 2005; 13: 1661
      CrossrefPubMed
    • 2e Gao GY, Li DJ, Keung WM. J. Med. Chem. 2001; 44: 3320
      Crossref
    • 3a Traxler P, Green J, Mett H, Sequin U, Furet P. J. Med. Chem. 1999; 42: 1018
      CrossrefPubMed
    • 3b Kim YW, Hackett JC, Brueggemeier RW. J. Med. Chem. 2004; 47: 4032
      CrossrefPubMed
    • 3c Su B, Hackett JC, Diaz-Cruz ES, Kim YW, Brueggemeier RW. Bioorg. Med. Chem. 2005; 13: 6571
      CrossrefPubMed
    • 4a Cushman M, Zhu H, Geahlen RL, Kraker AJ. J. Med. Chem. 1994; 37: 3353
      Crossref
    • 4b Akama T, Shida Y, Sugaya T, Ishida H, Gomi K, Kasai M. J. Med. Chem. 1996; 3461
    • 4c Ahn YM, Vogeti L, Liu C.-J, Santhapuram HK. R, White JM, Vasandani V, Mitscher LA, Lushington GH, Hanson PR, Powell DR, Himes RH, Roby KF, Ye Q, Georg GI. Bioorg. Med. Chem. 2007; 15: 702
      CrossrefPubMed
    • 4d Larget R, Lockhart B, Renard P, Largeron M. Bioorg. Med. Chem. Lett. 2000; 10: 835
      Crossref
    • 5a Konan NA, Lincopan N, Díaz IE. C, de Fatima Jacysyn J, Tiba MM. T, Mendes JG. P. A, Bacchi EM, Spira B. Exp. Toxicol. Pathol. 2012; 64: 435
      Crossref
    • 5b Bedir E, Talti II, Khan RA, Zhao J, Takamatsu S, Walker LA, Goldman P, Khan AA. J. Agric. Food Chem. 2002; 50: 3150
      Crossref
    • 5c Beara IN, Lesjak MM, Cetojevic-Simin DD, Marjanovic ZS, Ristic JD, Mrkonjic ZO, Mimica-Dukic NM. Food Chem. 2014; 165: 460
      CrossrefPubMed
    • 5d Cherry JJ, Rietz A, Malinkevich A, Liu Y, Xie M, Bartolowits M, Davisson VJ, Baleja JD, Androphy EJ. PLoS One 2013; 8: e84506
      Crossref
    • 5e Dao TT, Kim SB, Sin K.-S, Kim S, Kim HP, Park H. Arch. Pharm. Res. 2004; 27: 278
      Crossref
    • 5f Lu S, Sun S.-L, Liu H.-C, Chen Y.-D, Yuan H.-L, Gao Y.-P, Lu PY. T. Chem. Biol. Drug. Des. 2012; 80: 328
      CrossrefPubMed
    • 5g Park H, Dao TT, Kim HP. Eur. J. Med. Chem. 2005; 40: 943
      CrossrefPubMed
    • 5h Finlay MR. V, Griffin RJ. Bioorg. Med. Chem. Lett. 2012; 22: 5352
      Crossref
    • 6a Miyaura N, Yamada K, Suzuki A. Tetrahedron Lett. 1979; 36: 3437
    • 6b Miyaura N, Suzuki A. Chem. Commun. 1979; 866
    • 6c Miyaura N, Suzuki A. Chem. Rev. 1995; 95: 2457
    • 7a Suzuki A. Pure Appl. Chem. 1985; 57: 1749
      Crossref
    • 7b de Meijere A, Diederich F. Metal-Catalyzed Cross-Coupling Reactions . Wiley-VCH; Weinheim: 2004. 2nd ed., Vol. 1 and 2
      CrossrefGoogle Scholar
    • 7c Beller M, Bolm C. Transition Metals for Organic Synthesis: Building Blocks and Fine Chemicals . Wiley-VCH; Weinheim: 2004. 2nd ed., Vol. 1 and 2
      CrossrefGoogle Scholar
    • 7d Negishi E.-i. Handbook of Organopalladium for Organic Synthesis . Vol. 1 and 2. Wiley-Interscience; New York: 2002
      Google Scholar
    • 7e Ackermann L. Modern Arylation Methods . Wiley-VCH; Weinheim: 2009
      CrossrefGoogle Scholar
    • 7f Tsuji J. Palladium Reagents and Catalysts . 2nd ed. Wiley; Chichester: 2004
      CrossrefGoogle Scholar
    • 7g King AO, Yasuda N. Organometallics in Process Chemistry . Larsen RD. Springer; Berlin: 2004
      Google Scholar
    • 7h Suzuki A. Modern Arene Chemistry . Astruc D. Wiley-VCH; Weinheim: 2002
      Google Scholar
    • 7i Miyaura N. Top. Curr. Chem. 2002; 219: 11
    • 7j Suzuki A. J. Organomet. Chem. 2002; 653: 54
      Crossref
    • 7k Roglans A, Pla-Quintana A, Moreno-Mañas M. Chem. Rev. 2006; 106: 4622
      CrossrefPubMed
    • 7l Hassan J, Sévignon M, Gozzi C, Schulz E, Lemaire M. Chem. Rev. 2002; 102: 1359
      CrossrefPubMed
    • 7m Yin L, Liebscher J. Chem. Rev. 2007; 107: 133
      CrossrefPubMed
    • 7n Wu XF, Anberasan P, Neumann H, Beller M. Angew. Chem. Int. Ed. 2010; 49: 9047
      Crossref
    • 7o Corbet J.-P, Mignani G. Chem. Rev. 2006; 106: 2651
      CrossrefPubMed
    • 8a Rataboul F, Zapf A, Jackstell R, Harkal S, Riermeier T, Monsees A, Dingerdissen U, Beller M. Chem. Eur. J. 2004; 10: 2983
      CrossrefPubMed
    • 8b Zapf A, Jackstell R, Rataboul F, Riermeier T, Monsees A, Fuhrmann C, Shaikh N, Dingerdissen U, Beller M. Chem. Commun. 2004; 38
    • 8c Wolfe JP, Tomori H, Sadighi JP, Yin J, Buchwald SL. J. Org. Chem. 2000; 65: 1158
      CrossrefPubMed
    • 8d Nishiyama M, Yamamoto T, Koie Y. Tetrahedron Lett. 1998; 39: 617
      Crossref
    • 9a Hassan Z, Hussain M, Langer P. Synlett 2011; 1827
      Article in Thieme Connect
    • 9b Littke AF, Dai CY, Fu GC. J. Am. Chem. Soc. 2000; 122: 4020
      Crossref
    • 9c Kamikawa T, Hayashi T. Tetrahedron Lett. 1997; 38: 7087
      Crossref
    • 9d Hassan Z, Hussain M, Villinger A, Langer P. Tetrahedron 2012; 68: 6305
      Crossref
    • 9e Roy AH, Hartwig JF. Organometallics 2004; 23: 194
      Crossref
    • 9f Espino G, Kurbangalieva A, Brown JM. Chem. Commun. 2007; 1742

      For reviews of site-selective palladium(0)-catalyzed cross-coupling reactions, see:
    • 10a Wang R, Manabe K. Synthesis 2009; 1405
      Article in Thieme Connect
    • 10b Schnürch M, Flasik R, Khan AF, Spina M, Mihovilovic MD, Stanetty P. Eur. J. Org. Chem. 2006; 3283
    • 10c For a simple guide for predicting the site selectivity of palladium-catalyzed cross-coupling reactions based on 1H NMR spectroscopic data of the nonhalogenated derivatives, see: Handy ST, Zhang Y. Chem. Commun. 2006; 299
    • 11a Zahid H, Patonay T, Langer P. Synlett 2013; 24: 412
      Article in Thieme Connect
    • 11b Malik I, Hussain M, Hung NT, Villinger A, Langer P. Synlett 2010; 2244
      Article in Thieme Connect
    • 11c Eleya N, Malik I, Reimann S, Wittler K, Hein M, Patonay T, Villinger A, Ludwig R, Langer P. Eur. J. Org. Chem. 2012; 1639
    • 12a Blatt AH. Org. React. 1942; 1: 342
    • 12b Patwari SB, Baseer MA, Vibhute YB, Bhusare SR. Tetrahedron Lett. 2003; 44: 4893
      Crossref
    • 12c Singh PP, Thatikonda T, Kumar KA. A, Sawant SD, Singh B, Sharma AK, Sharma PR, Singh D, Vishwakarma RA. J. Org. Chem. 2012; 77: 5823
    • 13a Claisen L, Claparède A. Ber. Dtsch. Chem. Ges. 1881; 14: 2460
      Crossref
    • 13b Schmidt JG. Ber. Dtsch. Chem. Ges. 1881; 14: 1459
      Crossref
    • 14a Fekete S, Patonay T, Silva AM. S, Cavaleiro JA. S. ARKIVOC 2012; (v): 210
    • 14b Dao TT, Chi YS, Kim J, Kim HP, Kim S, Park H. Bioorg. Med. Chem. Lett. 2004; 14: 1165
      Crossref
    • 14c Cabrera M, Simoens M, Falchi G, Lavaggi ML, Piro OE, Castellano EE, Vidal A, Azqueta A, Monge A, Ceráin AL, Sagrera G, Seoane G, Cerecettoa H, González M. Bioorg. Med. Chem. 2007; 15: 3356
      CrossrefPubMed
    • 14d Chimenti F, Fioravanti R, Bolasco A, Chimenti P, Secci D, Rossi F, Yáñez M, Orallo F, Ortuso F, Alcaro S, Cirilli R, Ferretti R, Sanna ML. Bioorg. Med. Chem. 2010; 18: 1273
      CrossrefPubMed
  • 15 Procedure for Synthesising 6,8-Diarylflavone Derivatives 6a–g To a mixture of 6,8-dibromoflavone (4, 95 mg, 0.25 mmol), K3PO4 (160 mg, 0.75 mmol), and boronic acid 5 (0.75 mmol) in dry dioxane (4 mL), Pd(PPh3)4 (17 mg, 0.015 mmol) was added in a dried pressure tube under argon. The reaction mixture was stirred and heated in an aluminum heating block till full conversion. The solvent was removed under reduced pressure, and the solid mixture was dissolved in CH2Cl2. The solution was submitted to adsorptive filtration on silica gel using CH2Cl2 as eluent to remove the inorganic compounds. The CH2Cl2 was evaporated; the residue was washed two times with acetone then filtered to give the pure cross-coupled product 6.
    • 16a Procedure for Synthesising 8-Aryl-6-bromoflavone Derivatives 7a–d To a mixture of 6,8-dibromoflavone (4, 95 mg, 0.25 mmol), K3PO4 (106 mg, 0.5 mmol), and boronic acid 5 (0.30 mmol) in dry dioxane (4 mL), Pd(PPh3)4 (17 mg, 0.015 mmol) was added in a dried pressure tube under argon. The reaction mixture was stirred and heated at 80 °C for 48 h in an aluminum heating block. The solvent was removed in vacuum, and the solid mixture was dissolved in CH2Cl2. The solution was submitted to adsorptive filtration on silica gel using CH2Cl2 as eluent to remove the inorganic compounds. The eluted solution was concentrated then the mixture was purified by column chromatography (eluent: heptane–EtOAc mixture; the ratio is given at the compound) to give the monosubstituted product.
    • 16b 1H NMR Spectroscopic Data of Flavone 1H NMR (400 MHz, CDCl3): δ = 8.24 (d, J = 8.9 Hz, 1 H, 5-H), 7.97–7.89 (m, 2 H, 2′,6′-H), 7.70 (t, J = 8.4 Hz, 1 H, 7-H), 7.58 (d, J = 8.3 Hz, 1 H, 8-H), 7.56–7.50 (m, 3 H, 3′,4′, 5′-H), 7.43 (t, J = 7.5 Hz, 1 H, 6-H), 6.83 (s, 1 H, 3-H).
  • 17 CCDC-1052200 contains all crystallographic details of this publication and is available free of charge at www.ccdc.cam.ac.uk/conts/retrieving.html.
  • 18 Procedure for Synthesizing Differently Substituted 6,8-Diarylflavone Derivatives 9a–d To a mixture of 8-aryl-6-bromoflavones 7c,d (0.10 mmol), K3PO4 (54 mg, 0.25 mmol), and boronic acid 5a,e (0.20 mmol) in dry dioxane (4 mL), Pd(PPh3)4 (5.8 mg, 0.005 mmol) was added in a dried pressure tube under argon. The reaction mixture was stirred and heated at 100 °C for 2 h in an aluminum heating block. The solvent from the crude reaction mixture was removed in vacuum, and the solid residue was dissolved in CH2Cl2. The solution was submitted to adsorptive filtration on silica gel using CH2Cl2 as eluent to remove the inorganic compounds. The eluted solution was concentrated, then the mixture was purified by column chromatography (eluent: heptane–EtOAc mixture; the ratio is given at the compound) to give the nonsymmetric diarylated product.
  • 19 6,8-Bis(4-methylphenyl)flavone (6a) Starting with 4 (95 mg, 0.25 mmol), K3PO4 (160 mg, 0.75 mmol), Pd(PPh3)4 (17 mg, 0.015 mmol, 6 mol%), (4-methylphenyl)boronic acid (5a, 102 mg, 0.75 mmol), and 1,4-dioxane (4 mL), 6a was isolated as a light yellow solid (94 mg 93%), mp 247.0–248.5 °C. 1H NMR (300 MHz, 298 K, CDCl3): δ = 8.44 (d, J = 2.7 Hz, 1 H, 5-H), 7.96 (d, J = 2.4 Hz, 1 H, 7-H), 7.82–7.79 (m, 2 H, 2′,6′-H), 7.64–7.59 (m, 4 H, 2′′,6′′-H, 2′′′,6′′′-H), 7.49.7.46 (m, 3 H, 3′,5′-H, 4′-H), 7.37 (d, J = 9.6 Hz, 2 H, 3′′′,5′′′-H), 7.27 (d, J = 9.6 Hz, 2 H, 3′′,5′′-H), 6.96 (s, 1 H, 3-H), 2.50 (s, 3 H, 4′′′-CH3), 2.42 (s, 3 H, 4′′-CH3). 13C NMR (75 MHz, 298 K, CDCl3): δ = 178.7 (C-4), 163.2 (C-2), 152.4 (C-8a), 138.1 (C-4′′,4′′′), 137.8 (C-6), 136.4 (C-8), 133.4 (C-7), 133.2 (C-1′′), 132.3 (C-1′′′), 131.6 (C-1′), 131.5 (C-4′), 129.7 (C-3′′,5′′), 129.5 (C-3′′′,5′′′), 129.1 (C-2′′′,6′′′), 129.0 (C-3′,5′), 127.0 (C-2′′,6′′), 126.3 (C-2′,6′), 124.5 (C-4a), 122.1 (C-5), 126.9 (C-3), 21.3 (4′′′-CH3), 21.1 (4′′-CH3). IR (ATR): ν = 1636, 1597, 1459, 1447, 1363, 1173, 812, 775, 687, 633, 502 cm–1. GC-MS (EI, 70eV): m/z (%) = 402 (100) [M+•], 300, 229, 102. HRMS: m/z calcd for C29H22O2: 402.16143; found: 402.16156. 6-Bromo-8-(3,4-dimethoxyphenyl)flavone (7c) Starting with 4 (95 mg, 0.25 mmol), K3PO4 (106 mg, 0.5 mmol), Pd(PPh3)4 (17 mg, 0.015 mmol, 6 mol%), (3,4-dimethylphenyl)boronic acid (5c, 55 mg, 0.30 mmol), and 1,4-dioxane (4 mL), 7c was isolated as a white solid (62 mg 57%), mp 186.5–188 °C (eluent: heptane–EtOAc, 2:1). 1H NMR (300 MHz, 298 K, CDCl3): δ = 8.31 (d, 1 H, J = 2.4 Hz, 5-H), 7.80 (d, 1 H, J = 2.4 Hz, 7-H), 7.77–7.75 (m, 2 H, 2′,6′-H), 7.51–7.45 (m, 3 H, 3′,5′-H, 4′-H), 7.18–7.15 (m, 2 H, 2′′,6′′-H), 7.04 (d, J = 8.1 Hz, 1 H, 5′′-H), 6.88 (s, 1 H, 3-H), 3.99 (s, 3 H, 4′′-OCH3), 3.88 (s, 3 H, 3′′-OCH3). 13C NMR (75 MHz, 298 K, CDCl3): δ = 177.1 (C-4), 163.3 (C-2), 151.9 (C-8a), 149.4 (C-3′′), 148.7 (C-4′′), 137.0 (C-7), 133.8 (C-1′′), 131.8 (C-4′), 131.2 (C-1′), 129.0 (C-3′,5′), 127.3 (C-8), 126.9 (C-5), 126.2 (C-2′,6′), 125.6 (C-4a), 122.2 (C-6′′), 118.6 (C-6), 112.6 (C-2′′), 111.1 (C-5′′), 106.9 (C-3), 55.9 (3′′-OCH3, 4′′-OCH3). IR: (ATR): ν = 3061, 2999, 2933, 2838, 1637, 1567, 1512, 1452, 1358, 1251, 1224, 1137, 1022, 882, 780, 694, 670, 637, 589 cm–1. GC-MS (EI, 70eV): m/z (%) = 436 [M+•], 438 [M+• + 2], 293, 291, 184, 102. HRMS: m/z calcd for C23H17O4 79Br: 436.03047; found: 436.03046; m/z calcd for C23H17O4 81Br: 438.02843; found: 438.02866. 6-(4-Chlorophenyl)-8-(3,4-dimethoxyphenyl)flavone (9b) Starting with 7c (44 mg, 0.10 mmol), K3PO4 (42 mg, 0.2 mmol), Pd(PPh3)4 (5.8 mg, 0.005 mmol, 5 mol%), (4-chlorophenyl)boronic acid (5e, 31 mg, 0.20 mmol), and 1,4-dioxane (4 mL), 9b was isolated as a light yellow solid (38 mg, 81%), mp 228–229 °C (eluent: heptane–EtOAc, 2:1). 1H NMR (300 MHz, 298 K, CDCl3): δ = 8.40 (d, J = 3.0 Hz, 1 H, 5-H), 7.90 (d, J = 3.0 Hz, 1 H, 7-H) 7.82–7.90 (m, 2 H, 2′,6′-H), 7.64 (d, J = 8.1 Hz, 2 H, 2′′,6′′-H,) 7.52–7.43 (m, 5 H, 3′,5′-H, 4′-H, 3′′,5′′-H), 7.25–7.21 (m, 2 H, 2′′′,6′′′-H), 7.07 (d, J = 8.1 Hz, 1 H, 5′′′-H), 6.93 (s, 1 H, 3-H), 4.00 (s, 3 H, 4′′′-OCH3), 3.90 (s, 3 H, 3′′-OCH3). 13C NMR (75 MHz, 298 K, CDCl3): δ = 178.4 (C-4), 163.2 (C-2), 152.6 (C-8a), 149.3 (C-3′′′), 148.8 (C-4′′′), 137.7 (C-1′′), 136.9 (C-6), 134.1 (C-4′′), 133.1 (C-7), 132.4 (C-1′′′), 131.8 (C-4′), 131.5 (C-1′), 129.2 (C-3′,5′), 129.1 (C-3′′,5′′), 128.6 (C-8), 128.4 (C-2′′,6′′), 126.3 (C-2′,6′), 124.7 (C-4a), 122.3 (C-5), 122.2 (C-6′′′), 112.9 (C-2′′′), 111.2 (C.5′′′), 106.9 (C-3), 56.0 (3′′′-OCH3, 4′′′-OCH3). IR (ATR): ν = 2957, 2834, 1640, 1514, 1461, 1243, 1225, 1141, 1029, 821, 688 cm–1. GC-MS (EI, 70eV): m/z (%) = 468 [M+•], 470 [M+• + 2], 425, 323, 189, 102. HRMS: m/z calcd for C29H21O4 35Cl: 468.11229; found: 468.11195.